Showing results (91-100 of 309) with videos related to

Sort By:
Pageof 31
Zeitschrift Fur Rheumatologie|September 21, 2021
[Methotrexate treatment before use of biologics in rheumatoid arthritis : Analysis of guideline compliance]Nicolas Pardey, Jan Zeidler, Tim Fritz Nellenschulte, et al.
Frontiers in Immunology|June 2, 2020
Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients-Lessons Learned From SARS and MERSNora Möhn, Refik Pul, Christoph Kleinschnitz, et al.
AIDS Research and Human Retroviruses|November 15, 2011
NKG2C deletion is a risk factor of HIV infectionRachel Thomas, Hui Zhi Low, Katja Kniesch, et al.
Zeitschrift Fur Rheumatologie|September 18, 2021
Work situation of rheumatologists and residents in times of COVID-19 : Findings from a survey in GermanyEllen Kuhlmann, Luzia Bruns, Kirsten Hoeper, et al.
Deutsche Medizinische Wochenschrift (1946)|April 27, 2019
[Actual Treatment Options for Giant Cell Arteritis]Frank Moosig, Marc Schmalzing, Peer Malte Aries, et al.
Frontiers in Immunology|April 12, 2019
Added Value of Anti-CD74 Autoantibodies in Axial SpondyloArthritis in a Population With Low HLA-B27 PrevalenceNelly R Ziade, Iyad Mallak, Georges Merheb, et al.
Clinical Rheumatology|March 3, 2009
Infection with Mycobacterium genavense in a patient with systemic lupus erythematosusJohan Lorenzen, Dirk Meyer-Olson, Marion Haubitz, et al.
The Journal of Rheumatology|April 3, 2010
Influence of STAT4 polymorphism in primary Sjögren's syndromeRogelio J Palomino-Morales, Lina-Marcela Diaz-Gallo, Torsten Witte, et al.
Modern Rheumatology|May 6, 2024
Immunological biomarkers in patients with radiographic axial spondyloarthritis, an exploratory longitudinal Swedish studyUrban Hellman, Kristina Lejon, Lan Do, et al.
Rheumatology and Therapy|January 12, 2026
Rationale, Design and Methods of the Filgotinib Initial Response Study in Rheumatoid Arthritis (FIRST-RA)Georg Pongratz, Rieke Alten, Torsten Witte, et al.
Pageof 31